MEI Pharma Inc (MEIP)
4.02
+0.10
(+2.55%)
USD |
NASDAQ |
Mar 28, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
MEI Pharma Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 105.38M |
June 30, 2023 | 48.82M |
March 31, 2023 | 58.77M |
December 31, 2022 | 62.57M |
September 30, 2022 | 41.67M |
June 30, 2022 | 40.70M |
March 31, 2022 | 36.74M |
December 31, 2021 | 35.15M |
September 30, 2021 | 35.92M |
June 30, 2021 | 34.80M |
March 31, 2021 | 51.69M |
December 31, 2020 | 44.82M |
September 30, 2020 | 33.24M |
June 30, 2020 | 27.76M |
March 31, 2020 | 4.539M |
December 31, 2019 | 4.544M |
September 30, 2019 | 5.584M |
June 30, 2019 | 4.915M |
March 31, 2019 | 4.333M |
December 31, 2018 | 3.517M |
September 30, 2018 | 1.827M |
June 30, 2018 | 1.622M |
March 31, 2018 | 1.523M |
December 31, 2017 | 5.595M |
September 30, 2017 | 22.44M |
Date | Value |
---|---|
June 30, 2017 | 23.25M |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.333M
Minimum
Mar 2019
105.38M
Maximum
Sep 2023
35.89M
Average
35.92M
Median
Sep 2021
Revenue (TTM) Benchmarks
Merck & Co Inc | 60.11B |
United Therapeutics Corp | 2.328B |
Macrogenics Inc | 56.91M |
Voyager Therapeutics Inc | 250.01M |
Moderna Inc | 6.754B |